AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0%

Mon, 16 Aug

AUROBINDO PHARMA has announced its results for the quarter ended June 2021. Here is a detailed performance review of the same:

AUROBINDO PHARMA Quarterly Financials

No. of Mths Qtr. Ending		3 Jun-20*	3 Mar-21*	3 Jun-21*	QoQ Change	YoY Change
Net Sales	Rs m	59,248	60,015	57,020	-5.0%	-3.8%
Other income	Rs m	1,156	781	1,099	40.7%	-4.9%
Turnover	Rs m	60,404	60,796	58,119	-4.4%	-3.8%
Expenses	Rs m	46,674	47,268	44,926	-5.0%	-3.7%
Gross profit	Rs m	12,574	12,754	12,094	-5.2%	-3.8%
Depreciation	Rs m	2,555	2,660	2,797	5.1%	9.5%
Interest	Rs m	211	182	129	-29.3%	-38.9%
Profit before tax	Rs m	10,964	10,692	10,267	-4.0%	-6.4%
Tax	Rs m	3,012	2,597	2,477	-4.6%	-17.7%
Profit after tax	Rs m	7,952	8,096	7,790	-3.8%	-2.0%
Gross profit margin	%	21.2	21.3	21.2
Effective tax rate	%	27.5	24.3	24.1
Net profit margin	%	13.2	13.3	13.4

Year-on-Year Performance:

• The company's operating income during the quarter fell 3.8% on a year-on-year (YoY) basis. The expenses were down by 3.7% YoY during the same period.
• The company's operating profit declined by 3.8% YoY during the quarter. Consequently, operating profit margins remained same and stood at 21.2% in 1QFY22.
• Depreciation charges increased by 9.5% and finance costs declined by 38.9% YoY, respectively.
• Other income declined by 4.9% YoY during the quarter.
• Net profit for the quarter declined by 2.0% YoY. Net profit margins during the quarter increased from 13.2% in 1QFY21 to 13.4% in 1QFY22.

Quarter-on-Quarter Performance:

• The company's operating income during the quarter fell 5.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 5.0% QoQ during the same period.
• The company's operating profit declined by 5.2% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 21.2% in 1QFY22 as against 21.3% in 4QFY21.
• Net profit for the quarter declined by 3.8% QoQ, while net profit margins increased from 13.3% in 4QFY21 to 13.4% in 1QFY22.

To see how AUROBINDO PHARMA has performed over the last eight quarters,please visit here.

Vote Now or Never: India's most trusted corporate. Click here.

AUROBINDO PHARMA Share Price Performance

Over the last one year, AUROBINDO PHARMA share price has moved down from Rs 878.2 to Rs 736.5, registering a Loss of Rs 141.7 or around 16.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 25,854.9 (down 0.1%). Over the last one year it has moved up from 19,114.4 to 25,854.9, a gain of 6,741 points (up 35.3%).

Overall, the S&P BSE SENSEX is up 44.8% over the year.

Current Valuations

At the current price of Rs 736.5, the price to earnings (P/E) ratio of AUROBINDO PHARMA stands at 8.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.0 times.